Detailed price information for Cardiol Therapeutics Inc (CRDL-T) from The Globe and Mail including charting and trades.

The Company's lead small molecule drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease.

RE46,363 All claims, counterclaims, affirmative defenses, and demands are dismissed without prejudice and without costs, disbursements, or attorneys’ fees to any party. The parties each ...

reporting outcomes in patients receiving Epidiolex/Epidyolex (cannabidiol, 100mg/mL oral solution) and concomitant clobazam. Results showed most care Jazz Pharmaceuticals plc (Nasdaq: JAZZ ...

Researchers from the Monash Milk Team have published a new study demonstrating the power of human milk as a highly effective ...

Cryptosporidiosis is responsible for significant diarrheal morbidity and mortality in under-5 children in low- and middle-income countries and in recent years clofazimine has been used as a treatment ...

Dr. Wimms brings two decades of sleep medicine industry and research expertise to her advisory role at Incannex. Dr. Wimms holds a Doctor of Philosophy (Ph.D.) in Medicine, and Master of Medicine ...

Fintepla (fenfluramine) has potential interactions with other medications and some supplements. These interactions could affect how well the drug works or cause harmful effects. Fintepla is used ...